Seborrhoeic dermatitis is a chronic inflammatory skin condition, affecting a few people in every 100. A May 2014 Cochrane Review assesses the effects of topical pharmacological interventions, and the findings are discussed in this podcast by Jos Verbeek from the Finnish Institute of Occupational Health in Kuopio.